On February 15 of this year, Congress passed national breast density legislation, which mandates all mammography reports and summaries notify women of their breast density. A trio of researchers discussed whether the law will help or confuse patients in a recent JAMA commentary.

The causes of renal cell carcinoma progression may be more complex than outlined in the Response Evaluation Criteria in Solid Tumors version 1.1 (RECIST 1.1), according to findings published May 14 in Radiology. One radiologist said the study should be a "wake up call" for the speciality.

Enhanced dual-source dual-energy CT (DECT) can help differentiate invasive adenocarcinomas from preinvasive lesions which appear as pure ground-glass nodules (pGGNs), according to a small study published in the American Journal of Roentgenology.

Researchers have combined a new imaging technique and imaging agent which utilizes a synthesized amino acid found in scorpion venom to help illuminate brain tumors during surgery.

“The results of this research are extremely exciting, as it will significantly impact clinical care,” reported study author Mishal Mendiratta-Lala, MD, with the division of abdominal radiology at Michigan Medicine in Ann Arbor.

The U.S. Nuclear Regulatory Commission (NRC) opened a 30-day public comment period seeking feedback on its draft document outlining training and experience requirements for administrating radiopharmaceuticals requiring a written directive.

The researchers analyzed the frequency and cancer yield of ACR Breast Imaging Reporting and Data System (BI-RADS) 3 lesions in patients who received baseline and non-baseline screening MRIs.

Peptide radionuclide therapy (PRRT) demonstrated long-term effectiveness in patients with malignant neuroendocrine tumors, reported authors of a study published in the Journal of Nuclear Medicine.